Chris Godwin

Wide Receiver

Age: 28
Free Agency: 2025 (Void)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $27,534,000 (10.92% of cap)
  • 2024 Cash Payout: $20,000,000 (10.04% of spending)
  • 2024 Cash to Cap Ratio: 0.73
  • Contract Value: $60,000,000 ($20,000,000 APY)
  • Fully Guaranteed Money: $40,000,000
  • Contract Ranking: 16/299 at WR

Current Contract

(Franchise, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202226$1,250,000$3,750,000$0$1,250,000$5,000,0002.4%
202327$1,080,000$7,534,000$0$1,080,000$8,614,0003.8%
2024 📝
March 18: Roster bonus due
28$18,500,000$7,534,000$1,500,000$0$27,534,00010.9%
2025 📝
February 20: Contract voids
29Void$7,534,000VoidVoid$18,852,0007.3%
202630Void$7,534,000VoidVoid$00.0%
202731Void$3,784,000VoidVoid$00.0%
Total$20,830,000$37,670,000$1,500,000$2,330,000$60,000,000

Contract Notes

Chris Godwin signed a three year, $60 million contract. $40 million is fully guaranteed. There are two void years for salary cap purposes.

Cash Flows

- fully earned money
- unearned or partially earned money
$20M
$40M
$60M
2022202320242025
Cash Due$20,000,000$20,000,000$20,000,000$20,000,000
Running Cash$0$20,000,000$40,000,000$60,000,000
Career Earnings: $60,631,664
Career APY: $8,661,666
Potential Earnings: $100,631,664
Total Guarantees: $56,646,041
Largest Cash Payment: $20,000,000 (2022)
Largest Cap Number: $27,534,000 (2024)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
BuccaneersDraftedExpired20174$3,284,164$821,041$663,041$4,648,664141.5%$1,162,166
BuccaneersFranchiseExpired20211$15,983,000$15,983,000$15,983,000$15,983,000100.0%$15,983,000
BuccaneersFranchiseActive20223$60,000,000$20,000,000$40,000,000$40,000,00066.7%$20,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Buccaneers7$60,631,664$8,661,666$34,245,6640.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Buccaneers$465,000$198,041$0$0$663,0410.4%$1,257,164
2018Buccaneers$581,500$198,041$0$0$779,5410.4%$581,500
2019Buccaneers$677,000$198,041$0$0$875,0410.5%$677,000
2020Buccaneers$2,133,000$198,041$0$0$2,331,0411.1%$2,133,000
2021Buccaneers$15,983,000$0$0$15,983,000$15,983,0008.8%$15,983,000
2022Buccaneers$1,250,000$3,750,000$0$1,250,000$5,000,0002.4%$20,000,000
2023Buccaneers$1,080,000$7,534,000$0$1,080,000$8,614,0003.8%$20,000,000
2024Buccaneers$18,500,000$7,534,000$1,500,000$0$27,534,00010.9%$20,000,000
2025Buccaneers$0$7,534,000$0$0$18,852,0007.3%$20,000,000
2026Buccaneers$0$7,534,000$0$0$00.0%$0
2027Buccaneers$0$3,784,000$0$0$00.0%$0
Total$40,669,500$38,462,164$1,500,000$18,313,000$80,631,664$100,631,664

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2017150040.2%46.0%000.002741415.3000
2018160064.2%1.1%000.005984214.3741
2019142082.5%0.2%188.0086133315.5900
2020123162.8%0.0%000.006584012.9700
2021140070.4%0.0%4215.3198110311.3500
2022152072.4%0.7%351.7010410239.8300
2023170080.9%0.2%4389.5183102412.3200

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$13,820,000$20,000,000
Injury Adjusted$13,820,000$20,000,000
test
OTC Valuation $4.3M $8.7M $13M $17.4M $21.7M APY $5M $10M $15M $20M $25M $9,208,000 $5,035,348

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.